• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素可增强正常髓样细胞和急性早幼粒细胞中PML及PML/RARα的表达,并与全反式维甲酸协同作用,诱导一株对维甲酸耐药的早幼粒细胞系成熟。

Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.

作者信息

Nason-Burchenal K, Gandini D, Botto M, Allopenna J, Seale J R, Cross N C, Goldman J M, Dmitrovsky E, Pandolfi P P

机构信息

Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Blood. 1996 Nov 15;88(10):3926-36.

PMID:8916959
Abstract

The PML gene is fused to the retinoic acid receptor alpha gene (RAR alpha) in the acute promyelocytic leukemia (APL) 15; 17 translocation. PML is expressed in diverse tissues and cell lines and localized in the nucleus with a typical speckled pattern. In the bone marrow, it is preferentially expressed in myeloid cells. PML appears to be transcriptionally regulated by class I and II interferons, which raises the possibility that interferons modulate the function and growth and differentiation potential of normal myeloid cells and precursors by activating PML-dependent pathways. Similarly, interferons could act on APL cells, alone or in combination with all-trans retinoic acid (RA), especially if the PML/RAR alpha fusion transcript that results from the t(15; 17) is induced by interferon. We report here that PML is expressed at low levels or not expressed in normal circulating human monocytes, lymphocytes, and polymorphonucleate cells, but is markedly induced by interferon; that PML and PML/RAR alpha expression is augmented by interferon in the NB4 APL cell line, which carries the t(15; 17), and in APL blasts from patients; that interferon inhibits growth and survival of NB4 APL cells in cooperation with RA; that interferons alone have minimal maturation effect on NB4 cells; and, finally, that interferon gamma, but not alpha or beta, induces maturation and growth suppression of NB4 cells with de novo retinoid resistance, and partially restores RA response.

摘要

在急性早幼粒细胞白血病(APL)的15;17易位中,早幼粒细胞白血病(PML)基因与维甲酸受体α基因(RARα)融合。PML在多种组织和细胞系中表达,定位于细胞核,呈典型的斑点状模式。在骨髓中,它优先在髓系细胞中表达。PML似乎受I类和II类干扰素的转录调控,这增加了干扰素通过激活PML依赖途径调节正常髓系细胞及其前体细胞的功能、生长和分化潜能的可能性。同样,干扰素可单独或与全反式维甲酸(RA)联合作用于APL细胞,特别是如果由t(15;17)产生的PML/RARα融合转录本由干扰素诱导。我们在此报告,PML在正常循环的人单核细胞、淋巴细胞和多形核细胞中低水平表达或不表达,但可被干扰素显著诱导;在携带t(15;17)的NB4 APL细胞系以及患者的APL原始细胞中,干扰素可增强PML和PML/RARα的表达;干扰素与RA协同抑制NB4 APL细胞的生长和存活;单独使用干扰素对NB4细胞的成熟作用最小;最后,γ干扰素而非α或β干扰素可诱导对维甲酸耐药的NB4细胞成熟并抑制其生长,并部分恢复其对RA的反应。

相似文献

1
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line.干扰素可增强正常髓样细胞和急性早幼粒细胞中PML及PML/RARα的表达,并与全反式维甲酸协同作用,诱导一株对维甲酸耐药的早幼粒细胞系成熟。
Blood. 1996 Nov 15;88(10):3926-36.
2
A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.一种对维甲酸耐药的急性早幼粒细胞白血病亚克隆表达一种显性负性的PML-RARα突变。
Blood. 1997 Jun 15;89(12):4282-9.
3
Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.非重排等位基因RARα或PML表达增加的急性早幼粒细胞白血病细胞的生长抑制
Oncogene. 1995 Jun 15;10(12):2307-14.
4
Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.维甲酸诱导的急性早幼粒细胞白血病分化涉及PML-RARα介导的II型转谷氨酰胺酶增加。
Blood. 1996 Mar 1;87(5):1939-50.
5
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.与t(15;17)急性早幼粒细胞白血病相关的PML/RARα重排的特征分析
Curr Top Microbiol Immunol. 1997;220:81-112. doi: 10.1007/978-3-642-60479-9_6.
6
The molecular genetics of acute promyelocytic leukemia.急性早幼粒细胞白血病的分子遗传学
Blood Rev. 1993 Jun;7(2):87-93. doi: 10.1016/s0268-960x(05)80018-9.
7
PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.PML/RARα+ U937突变体和NB4细胞系:维甲酸可恢复对维生素D3的单核细胞分化反应。
Cancer Res. 1994 Aug 15;54(16):4508-15.
8
Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.急性早幼粒细胞白血病细胞中主要融合产物的类视黄醇结合特性的表征。
Blood. 1997 Aug 1;90(3):1175-85.
9
cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.环磷酸腺苷(cAMP)信号传导对于表达早幼粒细胞白血病锌指蛋白-维甲酸受体α(PML-RARα)的维甲酸耐药性t(15;17)早幼粒细胞白血病NB4细胞成熟过程中核体(PODs)的恢复起决定性作用。
Oncogene. 1996 Jun 6;12(11):2451-9.
10
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.不同维甲酸耐药性早幼粒细胞白血病细胞的常见缺陷是端粒酶活性持续存在和核体紊乱。
Differentiation. 1997 Aug;61(5):321-31. doi: 10.1046/j.1432-0436.1997.6150321.x.

引用本文的文献

1
A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify.使用 Mogrify 进行白血病分化治疗的新型网络药理学方法。
Oncogene. 2022 Nov;41(48):5160-5175. doi: 10.1038/s41388-022-02505-5. Epub 2022 Oct 21.
2
Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes.干扰素诱导 IFITM1 和 IFITM3 的表达并抑制大鼠新生心肌细胞的增殖。
J Cell Biochem. 2012 Mar;113(3):841-7. doi: 10.1002/jcb.23412.
3
GRIM-19: A Double-edged Sword that Regulates Anti-Tumor and Innate Immune Responses.
GRIM-19:一把调控抗肿瘤和固有免疫反应的双刃剑。
Transl Oncogenomics. 2008 Mar 17;3:67-79.
4
GRIM-19 Expression and Function in Human Gliomas.GRIM-19在人类胶质瘤中的表达与功能
J Korean Neurosurg Soc. 2010 Jul;48(1):20-30. doi: 10.3340/jkns.2010.48.1.20. Epub 2010 Jul 31.
5
Cytokine-induced tumor suppressors: a GRIM story.细胞因子诱导的肿瘤抑制因子:GRIM 的故事。
Cytokine. 2010 Oct-Nov;52(1-2):128-42. doi: 10.1016/j.cyto.2010.03.009. Epub 2010 Apr 10.
6
Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas.核受体在头颈部鳞状细胞癌中的预后和治疗潜力。
J Oncol. 2009;2009:349205. doi: 10.1155/2009/349205. Epub 2009 Sep 24.
7
Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.靶向早幼粒细胞白血病蛋白:一种调节早幼粒细胞白血病核体的方法。
Int J Biol Sci. 2009 May 22;5(4):366-76. doi: 10.7150/ijbs.5.366.
8
UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation.UBE1L通过将PML结构域靶向进行ISG15化修饰来抑制PML/RARα。
Mol Cancer Ther. 2008 Apr;7(4):905-14. doi: 10.1158/1535-7163.MCT-07-0515.
9
Expression of promyelocytic leukemia protein increases during the differentiation of human neuroblastoma cells.早幼粒细胞白血病蛋白的表达在人神经母细胞瘤细胞分化过程中增加。
Virchows Arch. 2003 Mar;442(3):278-83. doi: 10.1007/s00428-002-0756-0. Epub 2003 Feb 11.
10
Interactions of herpes simplex virus type 1 with ND10 and recruitment of PML to replication compartments.1型单纯疱疹病毒与ND10的相互作用以及PML向复制区室的募集。
J Virol. 2001 Mar;75(5):2353-67. doi: 10.1128/JVI.75.5.2353-2367.2001.